These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8831080)

  • 1. Dexamethasone associated systemic hypertension in low birth weight babies with chronic lung disease.
    Smets K; Vanhaesebrouck P
    Eur J Pediatr; 1996 Jul; 155(7):573-5. PubMed ID: 8831080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dexamethasone on blood pressure in premature infants with bronchopulmonary dysplasia.
    Marinelli KA; Burke GS; Herson VC
    J Pediatr; 1997 Apr; 130(4):594-602. PubMed ID: 9108858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal response in very low birthweight babies after dexamethasone treatment for bronchopulmonary dysplasia.
    Ng PC; Blackburn ME; Brownlee KG; Buckler JM; Dear PR
    Arch Dis Child; 1989 Dec; 64(12):1721-6. PubMed ID: 2624478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which course of dexamethasone?
    Bloomfield FH; Knight DB; Harding JE
    Arch Dis Child Fetal Neonatal Ed; 1999 Jan; 80(1):F80. PubMed ID: 10325825
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhaled versus systemic steroids in chronic oxygen dependency of preterm infants.
    Dimitriou G; Greenough A; Giffin FJ; Kavadia V
    Eur J Pediatr; 1997 Jan; 156(1):51-5. PubMed ID: 9007492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible cardiac changes after dexamethasone treatment for bronchopulmonary dysplasia.
    Riede FT; Schulze E; Vogt L; Schramm D
    Pediatr Cardiol; 2001; 22(4):363-4. PubMed ID: 11455412
    [No Abstract]   [Full Text] [Related]  

  • 7. Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia.
    Ng PC; Wong GW; Lam CW; Lee CH; Fok TF; Wong MY; Wong W; Chan DC
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2429-32. PubMed ID: 9253312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease.
    Ohlsson A; Calvert SA; Hosking M; Shennan AT
    Acta Paediatr; 1992 Oct; 81(10):751-6. PubMed ID: 1421877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study.
    DeCastro M; El-Khoury N; Parton L; Ballabh P; LaGamma EF
    J Perinatol; 2009 Apr; 29(4):297-304. PubMed ID: 19052552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dexamethasone on blood pressure in premature infants with bronchopulmonary dysplasia.
    Adelman RD
    J Pediatr; 1998 Jan; 132(1):187. PubMed ID: 9470029
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.
    Stark AR; Carlo WA; Tyson JE; Papile LA; Wright LL; Shankaran S; Donovan EF; Oh W; Bauer CR; Saha S; Poole WK; Stoll BJ;
    N Engl J Med; 2001 Jan; 344(2):95-101. PubMed ID: 11150359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of dexamethasone on time averaged mean velocity in the middle cerebral artery in very low birth weight infants.
    Ohlsson A; Bottu J; Govan J; Ryan ML; Myhr T; Fong K
    Eur J Pediatr; 1994 May; 153(5):363-6. PubMed ID: 7913442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient increase in intraocular pressure during a dose-tapering regime of systemic dexamethasone in preterm infants.
    Ng PC; Lee CH; Tam BS; Wong SP; Lam HS; Kwok AK; Fok TF
    Ophthalmology; 2008 May; 115(5):e7-14. PubMed ID: 18321580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia.
    Werner JC; Sicard RE; Hansen TW; Solomon E; Cowett RM; Oh W
    J Pediatr; 1992 Feb; 120(2 Pt 1):286-91. PubMed ID: 1735831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation.
    Kazzi NJ; Brans YW; Poland RL
    Pediatrics; 1990 Nov; 86(5):722-7. PubMed ID: 2235226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertrophic cardiomyopathy in a low-birth-weight newborn treated with dexamethasone].
    Villa Alcázar M; Pellicer Martínez A; Burgueros Valero M; Quero Jiménez J
    An Esp Pediatr; 1996 Apr; 44(4):393-4. PubMed ID: 8796947
    [No Abstract]   [Full Text] [Related]  

  • 18. Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia.
    Williams AF; Jones M
    Arch Dis Child; 1992 Jan; 67(1 Spec No):5-9. PubMed ID: 1536587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal steroids for the treatment of bronchopulmonary dysplasia: a complex case presentation.
    Forest S
    J Perinat Neonatal Nurs; 2011; 25(3):283-91; quiz 292-3. PubMed ID: 21825919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: a randomized trial.
    Bloomfield FH; Knight DB; Harding JE
    J Pediatr; 1998 Sep; 133(3):395-400. PubMed ID: 9738724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.